Medtech companies directory 2026

    Medical Device Companies in Brazil

    Brazilian hospital technology lives behind an Anvisa registro and a SUS invoice: the federal regulator clears the SKU, the Ministry of Health and the municipal/state secretarias buy for the public system, and Unimed and Hapvida buy for the private system on a completely different clock.

    Baumer and Fanem are the Brazilian manufacturers a public-hospital biomedical engineer already meets on furniture, sterilisation and neonatal equipment. WEG appears on hospital briefs as the industrial house that electrifies and automates plant rooms — relevant to capital projects, not as a cath-lab implant peer. Siemens Healthineers Brasil, GE HealthCare Brasil and B. Braun Brasil keep São Paulo organisations that bid SUS lots and still appoint distributors for interior municipalities. Anvisa is the registro and Cadastro gate. SUS procurement through the Ministry and the fundos municipais is the public volume. Unimed cooperatives and Hapvida NotreDame Intermédica are the private buyers. BioNixus fields named secretarias and named Unimed cooperativas, not a single “Brazil hospital” TAM.

    Updated September 2026 · Anvisa — Agência Nacional de Vigilância Sanitária, medical device registro and Cadastro as of September 2026 · 16 named accounts

    Request a proposal for BrazilBrowse the 16 companies

    Anvisa

    National Health Surveillance Agency — device registro / Cadastro gate

    SUS

    Public system whose Ministry and municipal secretarias take the largest equipment lots

    Unimed / Hapvida

    Private-operator doors that buy on a different clock from SUS

    Interior

    Municipal hospitals whose distributors, not São Paulo subsidiaries, hold the invoice

    Named accounts

    Top medical device companies in Brazil

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Anvisa — Agência Nacional de Vigilância Sanitária, medical device registro and Cadastro (as of 2026-09-05).
    #CompanyHQ
    01Anvisa (Agência Nacional de Vigilância Sanitária)Brasília
    02SUS / Ministry of Health procurementBrasília / state and municipal secretarias
    03BaumerSão Paulo state
    04FanemGuarulhos
    05WEG (hospital plant and automation, honestly scoped)Jaraguá do Sul
    06Siemens Healthineers BrasilSão Paulo
    07GE HealthCare BrasilSão Paulo
    08B. Braun BrasilRio de Janeiro / São Paulo
    09Unimed system — cooperative purchasingMultiple cooperativas
    10Hapvida NotreDame IntermédicaFortaleza / São Paulo
    11Brazilian importadores and hospital distributorsSão Paulo / Campinas / Porto Alegre
    12Philips Brasil (Health Systems)São Paulo
    13Medtronic BrasilSão Paulo
    14Hospital das Clínicas / university-hospital buying (USP and peers)São Paulo / state capitals
    15Cristália / other Brazilian hospital-adjacent manufacturersItapira / multiple
    16State and municipal secretarias de saúde (named-account layer)State capitals and municípios

    Primary research

    These are the medical device companies accounts we study in Brazil

    Need account-level or SKU-level data for a brand in Brazil? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in Brazil?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in Brazil (2026)

    How the market is structured

    Registro, SUS lot, Unimed desk

    A device that will be used in a Brazilian public hospital needs an Anvisa registro or Cadastro held by a Brazilian legal entity — fabricante or importador — and a place on a Ministry of Health, state or municipal tender that SIASG and the fundos de saúde actually pay. That is a different object from an FDA or MDR certificate a Miami Latin America hub waves at a São Paulo biomedical engineer. Capital equipment for SUS hospitals is specified by the user department and purchased by the secretaria or the federal programme (oncology, imaging, neonatal). Baumer wins a share of furniture, sterilisation and OR-support lots; Fanem still owns a large neonatal installed base in public maternities; Siemens and GE win high-end imaging rooms in capital-city teaching hospitals and lose more interior lots to price and service-coverage scores. Consumables and implants ride distributors: B. Braun Brasil manufactures and imports infusion and surgical lines; specialist importadores hold Anvisa files for niche surgical books; municipal stores pay the distributor, not the multinational’s Vila Olímpia seat. Unimed cooperativas and Hapvida NotreDame Intermédica buy as private operators — faster capital in some cooperativas, aggressive standardisation in Hapvida. WEG is the hospital plant-room and power-quality name on a turnkey project, and BioNixus will not pretend it sells stents. Interior São Paulo, Minas, Nordeste and Sul secretarias are four maps. BioNixus reconstructs the named Anvisa number, the named secretaria lot and the named Unimed or Hapvida desk before a Brazil volume figure is treated as real.

    Local

    Baumer, Fanem and honestly scoped industrial names such as WEG on plant rooms — Brazilian factories that SUS lots already know.

    • Baumer
    • Fanem
    • WEG (hospital plant and automation, honestly scoped)
    • Cristália / other Brazilian hospital-adjacent manufacturers

    Multinational

    São Paulo seats of Siemens, GE, Philips, B. Braun and Medtronic that win teaching-hospital rooms and still share interior invoices with importadores.

    • Siemens Healthineers Brasil
    • GE HealthCare Brasil
    • B. Braun Brasil
    • Philips Brasil (Health Systems)
    • Medtronic Brasil

    Regional

    Importadores and municipal distributors who hold the Anvisa file and the secretaria last-mile outside the capital-city teaching hospitals.

    Distributors & service partners

    Anvisa as the registro, SUS Ministry and secretarias as the public lot, Unimed cooperativas and Hapvida as the private desks.

    • Anvisa (Agência Nacional de Vigilância Sanitária)
    • SUS / Ministry of Health procurement
    • Unimed system — cooperative purchasing
    • Hapvida NotreDame Intermédica
    • Brazilian importadores and hospital distributors
    • Hospital das Clínicas / university-hospital buying (USP and peers)
    • State and municipal secretarias de saúde (named-account layer)

    What is moving

    What is moving the medical device market in Brazil

    Anvisa registro hygiene on the dock

    Secretaria stores now ask for the registro number on the carton; a Miami-hub SKU without a Brazilian holder is a failed delivery.

    SUS programme lots versus municipal envelopes

    Federal oncology or imaging programmes and municipal fundos de saúde open on different clocks; winning Brasília is not winning the município.

    Unimed fragmentation versus Hapvida standardisation

    Cooperativas buy locally; Hapvida standardises. A private-Brazil average of those two behaviours is a briefing error.

    Interior service coverage as a bid score

    Siemens and GE lose interior lots when the service van is a São Paulo fiction; BioNixus scores vans, not brand awareness.

    BioNixus fieldwork

    How BioNixus studies medical device companies in Brazil

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Brazil:
    • Anvisa registro-to-carton traces on municipal docks so a Miami-hub SKU is not counted as a Brazilian sale.
    • Named secretaria lot reconstructions in Minas, Bahia, Paraná and interior São Paulo, treated as four buyers.
    • Unimed cooperativa versus Hapvida protocol interviews so private volume is not one cell.
    • Interior service-van scores against São Paulo subsidiary claims on imaging and infusion lots.

    Healthcare market research in Brazil

    Questions

    Frequently Asked Questions

    How are medical devices registered in Brazil?

    Anvisa issues a registro or Cadastro to a Brazilian fabricante or importador. Classification drives the file. A secretaria store will ask for that number on the dock.

    Who buys devices for SUS hospitals?

    The Ministry of Health through federal programmes, plus state and municipal secretarias that open their own lots and pay through fundos de saúde. University hospitals add a third public specification layer.

    What do Unimed and Hapvida do as device buyers?

    Unimed cooperativas buy as local private systems. Hapvida NotreDame Intermédica standardises SKUs across a verticalised network. They are not one private catalogue.

    Is WEG a medical device company?

    WEG electrifies and automates hospital plant rooms. It belongs on a turnkey capital brief. It does not belong on an implant or imaging share slide.

    What does BioNixus study on Brazilian device accounts?

    Anvisa number-to-carton traces, named secretaria lot reconstructions, Unimed-versus-Hapvida desk interviews, and interior service-van scores beside São Paulo subsidiary claims.

    Is this a Brazilian market-share ranking?

    No. Names appear because they recur in BioNixus SUS and private-operator fieldwork; sequence is by role, not by revenue.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Brazil. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Anvisa — Agência Nacional de Vigilância Sanitária, medical device registro and Cadastro, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Brazil, not size.

    • Anvisa device registro / Cadastro guidance, consulted 2026
    • Ministry of Health and secretaria tender notices; SIASG-visible public awards
    • Baumer, Fanem, WEG, Siemens Healthineers Brasil, GE HealthCare Brasil and B. Braun Brasil published descriptions
    • BioNixus Brazil SUS, Unimed and Hapvida hospital fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in Brazil?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in Brazil?

    Primary research, market access & HEOR. Proposals within 48 hours.